TERAGENIX
biological agents, namely, vectors and retroviral vectors, for use in in-vitro diagnostic, biopharmaceutical, pharmaceutical and genomic industries; vector and retroviral vector manufacturing preparations, all for use in diagnostic and biopharmaceutical technology; molecular diagnostic preparations containing nucleic acids for assistance in manufacturing controls and/or reagents; and molecular and biopharmaceutical chemicals and biochemical preparations and solutions for use in the in-vitro d...
Abandoned · February 14, 2002 · 76373448 ·